Blogs at the CUNY Graduate School of Journalism

Posts Tagged ‘FDA’

Big Pharma Under Fire For Reverse Plagiarism

December 14th, 2008 by Heather Chin

The pharmaceutical industry is coming under fire for allegedly hiring ghostwriters (writers who work for pay, but not a byline) to write positive reports/analysis of clinical tests on drugs with possible efficacy issues – and then recruiting notable doctors to stick their names on it. This issue has been bandied about for months and suspected for longer, but now U.S. Senator Charles Grassley from Iowa is renewing the fight.

Is the fact that this possibility has surfaced doesn’t surprise me troubling? Even before I declared my concentration in health/medicine reporting, I was aware of the corruption and rampant abuse of power by what is referred to as Big Pharma. Government deregulation and regulation on a slew of business and healthcare policy issues end up benefiting these corporate entites, whether allowing unapproved drugs and drugs with possible side effects to go on the market before they are fully vetted by the FDA or removing/weakening price caps on prescription drugs so that Pharma can charge more for less and profit from donations of life-saving drugs to Third World countries. And of course there are the deceptive drug ads that have had varying levels of regulation over the last two decades.

Journal articles are an important “first draft” introducing new developments in medicine to the public and are among the sources used by health professionals and medical reporters in their story research. Doctors and reporters already look at journal articles with a wary eye, and the likely possibility of journal articles being fabricated can be even more detrimental to the trust people place in such written work.

And that doctors would sign on to put their names on these works they haven’t written – even if they agree with what is being written – is egregious and says they condone this deceptive practice. Like the regulations placed on drug advertisements, all that would be needed is for the doctors to acknowledge that this IS NOT their work. It would be better if it were, but if this is the way they want to roll, then disclose your affiliations.

It is tantamount to plagiarism.

Health Department Targets Deadly Cosmetics

September 25th, 2008 by Heather Chin

By Heather J. Chin

New York – City health officials stepped up their efforts in August to alert residents that some imported cosmetics threaten them with lead and mercury poisoning.

While federal and state standards already prohibit lethal cosmetics from entering the country, consumer demand keeps the supply steady, according to officials at the Board of Health during their quarterly meeting on Wednesday.

“The problem with global … products [is] that they are falling through the cracks,” said Dr. Nancy Clark, Assistant Commissioner of the department’s Bureau of Environmental Disease Prevention.

Specific deodorants, skin creams, aphrodisiacs and herbal remedies used by residents of Dominican, Indian and Chinese communities are on the list of products with poisonous ingredients.  These cosmetics are imported from Asia, Latin America, Africa and the Middle East.

Tests done by NYC’s health department and by others around the country have shown these products to have lead and mercury levels as much as 6,000 times higher than limits recommended by the U.S. Food and Drug Administration (FDA).  The FDA limit for lead levels is 10 parts per million; for mercury, it is 1 part per million.

At last month’s meeting, the board authorized the health department to find and remove dangerous cosmetics from store shelves, just as tainted food or drugs are.

These tools will come in the form of signs and fact sheets in the languages spoken by consumers, explained Ms. Paromita Hore, a risk assessment coordinator. “They’re often not aware” of the danger, she said, adding that use of the unhealthy products “is longstanding in their culture.”

At least in the Chinese community, such awareness efforts are welcome, says Gary Lee, the owner of a pharmacy in Chinatown that offers both U.S. name brands and popular Chinese medicines and herbs.

“[Officials] usually want to put pressure on the importer, not putting pressure on the shop,” he said. He notes that if a store has non-FDA approved drugs in stock, it is because they sell.  “What [the consumer] wants, they make a request.”

For Indian Americans, kohl and surma – two skin products listed by the Health Department as being laced with high levels of lead – pose a great threat because they are so embedded in the culture.

“Loving kohl is one of the commandments for being desi,” writes Anu, an Indian American freelance writer on her blog, The Indian Make-Up Diva.

When ingested or absorbed through the skin, high levels of lead and mercury can pose a danger to brain function, as well as to blood and renal system function.  These effects are particularly dangerous in children and pregnant women.